Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-05
2006-09-05
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S249000, C514S252110, C514S253060, C514S254040, C544S355000, C544S357000, C544S363000, C544S364000, C544S368000
Reexamination Certificate
active
07101886
ABSTRACT:
This invention relates to compounds of the formula 1wherein R1, R3, R4, X1, and X2are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system and other disorders.
REFERENCES:
patent: 4411901 (1983-10-01), Temple et al.
patent: 5173490 (1992-12-01), Peglion et al.
patent: 5350747 (1994-09-01), Howard
patent: 6127357 (2000-10-01), Cliffe et al.
patent: 2004/0067960 (2004-04-01), Davis et al.
patent: 2004/0138230 (2004-07-01), Andreana et al.
patent: 402644 (1990-12-01), None
patent: 1029861 (2000-08-01), None
patent: WO 93/04684 (1993-03-01), None
Cho Stephen Sung Yong
Graham James M.
Gregory Tracy Fay
Howard, Jr. Harry Ralph
Nikam Sham Shridhar
Ashbrook Charles W.
Bernhardt Emily
DeBenedictis Karen
Harvey Suzanne M.
Warner & Lambert Company
LandOfFree
Phenylalkyl and pyridylalkyl piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylalkyl and pyridylalkyl piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalkyl and pyridylalkyl piperazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3575329